W-S Min

1.2k total citations
29 papers, 737 citations indexed

About

W-S Min is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, W-S Min has authored 29 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 8 papers in Oncology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in W-S Min's work include Hematopoietic Stem Cell Transplantation (13 papers), Acute Myeloid Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (8 papers). W-S Min is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Acute Myeloid Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (8 papers). W-S Min collaborates with scholars based in South Korea. W-S Min's co-authors include Hyung Jun Kim, Dongwook Kim, YJ Kim, JW Lee, K-S Eom, B-S Cho, C-K Min, C-C Kim, Seok‐Goo Cho and Joo‐Heon Yoon and has published in prestigious journals such as British Journal of Cancer, Leukemia and Bone Marrow Transplantation.

In The Last Decade

W-S Min

29 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W-S Min South Korea	15	572	255	145	143	117	29	737
Douglas Rizzo United States	4	566 1.0×	190 0.7×	198 1.4×	137 1.0×	77 0.7×	8	675
Nobuyuki Aotsuka Japan	14	538 0.9×	113 0.4×	163 1.1×	180 1.3×	136 1.2×	67	695
Doug Rizzo United States	3	917 1.6×	318 1.2×	246 1.7×	274 1.9×	124 1.1×	3	1.1k
Sabine Fürst France	16	589 1.0×	141 0.6×	177 1.2×	191 1.3×	184 1.6×	46	727
Sabine Fürst France	20	843 1.5×	254 1.0×	316 2.2×	289 2.0×	89 0.8×	64	1.0k
David Stroncek United States	7	688 1.2×	139 0.5×	349 2.4×	183 1.3×	123 1.1×	15	834
Tokiko Nagamura Japan	7	463 0.8×	156 0.6×	150 1.0×	121 0.8×	70 0.6×	14	562
Ming Jiang China	10	672 1.2×	166 0.7×	237 1.6×	279 2.0×	156 1.3×	37	885
Pascual Balsalobre Spain	17	462 0.8×	118 0.5×	141 1.0×	252 1.8×	146 1.2×	57	782
J. H. Lipton Canada	15	508 0.9×	122 0.5×	114 0.8×	183 1.3×	242 2.1×	29	808

Countries citing papers authored by W-S Min

Since Specialization

Citations

This map shows the geographic impact of W-S Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W-S Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W-S Min more than expected).

Fields of papers citing papers by W-S Min

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W-S Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W-S Min. The network helps show where W-S Min may publish in the future.

Co-authorship network of co-authors of W-S Min

This figure shows the co-authorship network connecting the top 25 collaborators of W-S Min. A scholar is included among the top collaborators of W-S Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W-S Min. W-S Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jang, Woori, Joo‐Heon Yoon, Jong Kook Park, et al.. (2016). Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia. Blood Cancer Journal. 6(1). e387–e387. 14 indexed citations

Park, Jong Kook, et al.. (2015). Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length. Blood Cancer Journal. 5(8). e336–e336. 52 indexed citations

Kim, Myungshin, Dongwook Kim, YJ Kim, et al.. (2014). Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL. Bone Marrow Transplantation. 50(3). 354–362. 17 indexed citations

Sh, Shin, Je‐Hyun Yoon, Se Lee, et al.. (2014). PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL. Bone Marrow Transplantation. 49(6). 773–779. 4 indexed citations

Yoon, Joo‐Heon, Hyung Jun Kim, Jae Woo Kim, et al.. (2014). Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation. Bone Marrow Transplantation. 49(12). 1466–1474. 30 indexed citations

Yoon, Joo‐Heon, W-S Min, Jae‐Hong Kim, et al.. (2013). Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?. Bone Marrow Transplantation. 48(12). 1562–1568. 17 indexed citations

Kim, Hyung Jun, et al.. (2012). High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia. British Journal of Cancer. 107(1). 108–115. 11 indexed citations

Lee, Seung‐Hwan, Dongwook Kim, B-S Cho, et al.. (2012). Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia. 26(11). 2367–2374. 80 indexed citations

Sh, Shin, Joo‐Heon Yoon, Se Lee, et al.. (2012). Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure. Bone Marrow Transplantation. 48(5). 678–683. 12 indexed citations

10.

Lee, SoJung, B-S Cho, K-S Eom, et al.. (2010). Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia. Leukemia. 24(12). 2110–2119. 19 indexed citations

11.

Cho, B-S, Sae-Mi Lee, YJ Kim, et al.. (2009). Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study. Leukemia. 23(10). 1763–1770. 55 indexed citations

12.

Kim, Hyung Jun, W-S Min, B-S Cho, et al.. (2009). Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML. Bone Marrow Transplantation. 44(6). 345–351. 3 indexed citations

13.

Cho, B-S, C-K Min, K-S Eom, et al.. (2008). Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 41(9). 813–820. 56 indexed citations

14.

Kim, Hyung Jun, W-S Min, K-S Eom, et al.. (2007). Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia. Bone Marrow Transplantation. 40(11). 1069–1074. 12 indexed citations

15.

Kim, Hyung Jun, YJ Kim, K-S Eom, et al.. (2007). Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT. Bone Marrow Transplantation. 40(8). 723–728. 5 indexed citations

16.

Kim, Hyung Jun, W-S Min, YJ Kim, et al.. (2005). Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cells together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: a pilot study in a single Korean institution. Bone Marrow Transplantation. 35(10). 959–964. 10 indexed citations

17.

Kim, Hyung Jun, W-S Min, K-S Eom, et al.. (2004). Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission. Bone Marrow Transplantation. 34(3). 215–220. 20 indexed citations

18.

Kim, YJ, Dongwook Kim, Jae‐Yeon Hwang, et al.. (2003). Cytogenetic clonal evolution alone in CML relapse post-transplantation does not adversely affect response to imatinib mesylate treatment. Bone Marrow Transplantation. 33(2). 237–242. 8 indexed citations

19.

Kim, Dongwook, Seok‐Goo Cho, W-S Min, et al.. (1997). Pre-emptive ganciclovir treatment can play a role in restoration of hematopoiesis after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 19(2). 187–190. 4 indexed citations

20.

Dj, Kim, et al.. (1994). Allogeneic bone marrow transplantation in Korea: 1983-92.. PubMed. 13(6). 717–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact